» Articles » PMID: 18345311

Nonalcoholic Fatty Pancreas Disease

Overview
Journal HPB (Oxford)
Publisher Elsevier
Specialty Gastroenterology
Date 2008 Mar 18
PMID 18345311
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity leads to fat infiltration of multiple organs including the heart, kidneys, and liver. Under conditions of oxidative stress, fat-derived cytokines are released locally and result in an inflammatory process and organ dysfunction. In the liver, fat infiltration has been termed nonalcoholic fatty liver disease, which may lead to nonalcoholic steatohepatitis. No data are available, however, on the influence of obesity on pancreatic fat and cytokines, and nonalcoholic fatty pancreas disease (NAFPD) has not been described. Therefore, we designed a study to determine whether obesity is associated with increased pancreatic fat and cytokines.

Materials And Methods: Thirty C57BL/6J lean control and 30 leptin-deficient obese female mice were fed a 15% fat diet for 4 weeks. At 12 weeks of age all animals underwent total pancreatectomy. Pancreata from each strain were pooled for measurement of a) wet and dry weight, b) histologic presence of fat, c) triglycerides, free fatty acids (FFAs), cholesterol, phospholipids, and total fat, and d) interleukin (IL)-1beta and tumor necrosis factor-alpha (TNF-alpha). Data were analyzed by Student's t test and Fisher's exact test.

Results: Pancreata from obese mice were heavier (p<0.05) and had more fat histologically (p<0.05). Pancreata from obese mice had more triglycerides, FFAs, cholesterol, and total fat (p<0.05). Triglycerides represented 11% of pancreatic fat in lean mice compared with 67% of pancreatic fat in obese mice (p<0.01). Cytokines IL-1beta and TNF-alpha also were elevated in the pancreata of obese mice (p<0.05).

Conclusions: These data suggest that obese mice have 1) heavier pancreata, 2) more pancreatic fat, especially triglycerides and FFAs, and 3) increased cytokines. We conclude that obesity leads to nonalcoholic fatty pancreatic disease.

Citing Articles

Clinical features and outcomes of total pancreatic lipomatosis with chronic pancreatitis: a case series.

Rana S, Ancil S, Jayanna S, Kang M, Gupta R Ann Gastroenterol. 2025; 38(1):100-104.

PMID: 39802294 PMC: 11724381. DOI: 10.20524/aog.2025.0939.


Adherence to the dietary approaches to stop hypertension (DASH) and risk of pancreatic steatosis.

Fotros D, Tabar M, Chegini M, Bahrizadeh M, Sadeghi A, Rabbani A J Health Popul Nutr. 2024; 43(1):190.

PMID: 39567983 PMC: 11580558. DOI: 10.1186/s41043-024-00628-x.


Effect of adipose tissue deposition on insulin resistance in middle-aged and elderly women: Based on QCT and MRI mDIXON-Quant.

Liu Y, Gao L, Wu M, Yang B, Ren D, Zhang Z J Diabetes Investig. 2024; 16(2):292-297.

PMID: 39540298 PMC: 11786164. DOI: 10.1111/jdi.14352.


Extended Review and Updates of Nonalcoholic Fatty Pancreas Disease.

Habas E, Farfar K, Habas E, Rayani A, Elzouki A Saudi J Med Med Sci. 2024; 12(4):284-291.

PMID: 39539795 PMC: 11556510. DOI: 10.4103/sjmms.sjmms_526_23.


Computed tomography-based radiomics and body composition analysis for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy.

Wu H, Yu D, Li J, He X, Li C, Li S Gland Surg. 2024; 13(9):1588-1604.

PMID: 39421053 PMC: 11480874. DOI: 10.21037/gs-24-167.


References
1.
Walters M . Adipose atrophy of the exocrine pancreas. J Pathol Bacteriol. 1966; 92(2):547-57. DOI: 10.1002/path.1700920232. View

2.
Fernandez-Real J, Broch M, Vendrell J, Ricart W . Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care. 2003; 26(5):1362-8. DOI: 10.2337/diacare.26.5.1362. View

3.
Mokdad A, Ford E, Bowman B, Dietz W, Vinicor F, Bales V . Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2002; 289(1):76-9. DOI: 10.1001/jama.289.1.76. View

4.
Yan M, Li Y, Meng M, Ren H, Kou Y . Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia. Biochem Biophys Res Commun. 2006; 347(1):192-9. DOI: 10.1016/j.bbrc.2006.06.063. View

5.
Staiger H, Staiger K, Stefan N, Wahl H, Machicao F, Kellerer M . Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes. 2004; 53(12):3209-16. DOI: 10.2337/diabetes.53.12.3209. View